At the time of writing, Vincerx Pharma Inc [VINC] stock is trading at $0.82, down -2.26%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The VINC shares have gain 9.36% over the last week, with a monthly amount glided 32.07%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Vincerx Pharma Inc [NASDAQ: VINC] stock has seen the most recent analyst activity on January 14, 2022, when H.C. Wainwright initiated its Buy rating and assigned the stock a price target of $25. Previously, Cantor Fitzgerald started tracking the stock with Overweight rating on December 23, 2021, and set its price target to $25. On November 01, 2021, SVB Leerink initiated with a Outperform rating and assigned a price target of $24 on the stock. Laidlaw started tracking the stock assigning a Buy rating and suggested a price target of $30 on September 13, 2021. B. Riley Securities initiated its recommendation with a Buy and recommended $26 as its price target on August 25, 2021.
For the past year, the stock price of Vincerx Pharma Inc fluctuated between $0.51 and $9.37. Currently, Wall Street analysts expect the stock to reach $4 within the next 12 months. Vincerx Pharma Inc [NASDAQ: VINC] shares were valued at $0.82 at the most recent close of the market. An investor can expect a potential return of 387.8% based on the average VINC price forecast.
Analyzing the VINC fundamentals
Gross Profit Margin for this corporation currently stands at 0.2% with Operating Profit Margin at -23.36%, Pretax Profit Margin comes in at -22.0%, and Net Profit Margin reading is -22.0%. To continue investigating profitability, this company’s Return on Assets is posted at -1.34, Equity is -2.77 and Total Capital is -1.9. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.13.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.7600 points at the first support level, and at 0.7000 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.8600, and for the 2nd resistance point, it is at 0.9000.
Ratios To Look Out For
It is important to note that Vincerx Pharma Inc [NASDAQ:VINC] has a current ratio of 3.43. Also, the Quick Ratio is 3.43, while the Cash Ratio stands at 1.5.
